Fresno, California 2021-04-07 17:53:40 –
Duke researchers tested serum samples of the people who received them Moderna vaccine By introducing the COVID-19 variant. The vaccine maintained a strong defense, although its effectiveness was slightly reduced.
“Fortunately, California variants don’t seem to be a problem for current vaccines,” said research author David Montefiori, a professor and director of the AIDS Vaccine Research and Development Institute at Duke Surgery. “It’s important to know that this variant is now as prevalent in the United States as the British variant. Both appear to be highly contagious.”
They published their findings in the New England Journal of Medicine on April 7 as a research letter.
Researchers did not test the Pfizer-BioNTech vaccine. However, they said the results of such tests should be the same because the techniques used in both vaccines are similar.
Researchers have tested Novavax vaccine candidates. It will be considered for FDA approval in the coming weeks. The Novavax vaccine also worked well against the COVID-19 mutant in California.
However, both Novavax and Moderna were significantly less effective against the first variant identified in South Africa.
Copyright © 2021 KFSN-TV. all rights reserved.
2 vaccines in use will be effective against variant of COVID-19 identified in California, Duke finds Source link 2 vaccines in use will be effective against variant of COVID-19 identified in California, Duke finds